Canonical Pathwaysa | Nb | Top Associated Genesc | z-score |
---|---|---|---|
Heat + Saline | Â | Â | Â |
 --- | --- | --- | --- |
Thermoneutral + LPS | Â | Â | Â |
 GP6 Signaling Pathway | 11 | COL2A1, LAMA2, CAMK4, COL6A3, COL4A6 | 3.32 |
 Integrin Signaling | 11 | MYL9, ACTG2, ACTA2, MYLK, RND3 | 3.00 |
 Cardiac Hypertrophy Signaling | 10 | CACNA1E, HSPB1, MYL9, PLCL1, CAMK4 | 3.00 |
 Calcium Signaling | 11 | CACNA1E, CHRNA3, CHRNA7, TPM2, MYL9 | 2.65 |
 Signaling by Rho Family GTPases | 15 | FOS, MYL9, ACTG2, DES, ACTA2 | 2.50 |
 Thrombin Signaling | 10 | MYL9, PLCL1, MYLK, CAMK4, RND3 | 2.45 |
 Dopamine-DARPP32 Feedback in cAMP Signaling | 8 | CACNA1E, PLCL1, KCNJ8, PRKG1, DRD1 | 2.45 |
 ILK Signaling | 10 | FOS, MYL9, ACTG2, ACTA2, RND3 | 2.33 |
 Leukocyte Extravasation Signaling | 8 | MMP1, ACTG2, CTNNA2, ACTA2, JAM3 | 2.24 |
 CXCR4 Signaling | 7 | FOS, MYL9, EGR1, RND3, RHOB | 2.24 |
 PI3K Signaling in B Lymphocytes | 6 | FOS, ATF3, PLCL1, CAMK4, JUN | 2.24 |
 Cholecystokinin/Gastrin-mediated Signaling | 5 | FOS, RND3, RHOB, JUN, CREM | 2.24 |
 Tec Kinase Signaling | 6 | FOS, ACTG2, ACTA2, RND3, RHOB | 2.24 |
 Intrinsic Prothrombin Activation Pathway | 4 | COL2A1, COL1A2, COL1A1, COL3A1 | 2.00 |
 Agrin Interactions at Neuromuscular Junction | 5 | LAMA2, ACTG2, ACTA2, AGRN, JUN | 2.00 |
Heat + LPS | Â | Â | Â |
 Superpathway of Cholesterol Biosynthesis | 4 | PMVK, MVD, EBP, FDPS | -2.00 |
 Osteoarthritis Pathway | 15 | BGLAP, GLI1, IL1B, HES1, SP1 | -2.11 |
 Role of Wnt/GSK-3β Signaling in Pathogenesis of Influenza | 6 | WNT6, WNT10A, WNT11, FZD2, WNT5B | -2.24 |
 Wnt/Ca+ pathway | 6 | FZD2, WNT5B, PLCD4, PLCD3, RELA | -2.45 |
 PCP pathway | 8 | WNT6, WNT10A, WNT11, EFNB1, JUND | -2.82 |
 Colorectal Cancer Metastasis Signaling | 12 | WNT6, WNT10A, WNT11, PTGER2, IL6R | -2.89 |
 Glioblastoma Multiforme Signaling | 9 | WNT6, WNT10A, WNT11, EGF, FZD2 | -3.00 |